Name: FBIOP Income Statement - Fortress Biotech Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

FBIOP - Fortress Biotech, Inc.

USD | NASDAQ | Healthcare

FBIOP Income Statement - Fortress Biotech Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	16.0	16.1	17.6	16.4	13.1	15.1	14.6	14.9	13.0	19.9	34.8	17.4	12.4	16.4	16.5	18.9

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008
Revenues
Revenues	66.2	63.3	57.7	84.5	75.7	68.8	45.6	36.6	26.9	17.2	16.5	0.9	0.0	0.0	-	-	-	-	-
Cost of Revenue	22.4	20.9	20.9	22.9	30.8	32.1	14.6	10.5	6.1	3.7	0.8	0.0	-	-	-	-	-	-
Gross Profit	43.8	42.3	36.8	61.6	45.0	36.7	31.0	26.1	20.8	13.6	15.7	0.9	-	-	-	-	-
Operating Expenses
Research & Development	-	-	-	106.1	134.9	128.9	64.1	81.3	87.4	48.3	35.1	29.8	10.2	25.7	17.5
Operating Income
Operating Income	(55.6)	(70.2)	(110.4)	(142.3)	(203.6)	(188.5)	(94.3)	(110.8)	(120.0)	(89.8)	(65.7)	(50.5)	(20.7)	(35.8)
Non-Operating
Interest Income	2.6	2.5	2.7	3.0	1.4	0.6	1.5	2.6	1.1	0.8	0.3	0.2	0.7	0.5	0.2	0.2
Tax & Net
Income Tax Expense	4.5	(0.6)	0.3	0.5	0.4	0.5	0.5	0.0	0.0	1.5	0.0	0.0	-	-	-
Per Share
EPS Basic	3.78	(0.07)	(2.69)	(8.47)	(15.97)	(0.79)	-	-	-	-	-	-	-	-	-	-
Supplementary Data
EBITDA	(55.3)	(69.8)	(109.3)	(140.1)	(200.5)	(185.9)	(92.0)	(108.9)	(118.6)	(88.6)	(64.8)	(50.5)	(20.6)	(35.8)	(27.2)	(35.0)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	-	-	-	-	-	-	9.4	12.7	24.8	14.1	20.3	32.1	39.5	35.1	29.9	33.1	36.7	46.8	28.1	33.8	20.2	18.0	13.8	17.3	15.1	-	-	-	23.3	-	-	-	25.0	-	-	-	8.4	13.7	7.3	6.3
Selling General & Administrative	15.9	14.6	17.4	38.8	25.7	27.0	22.0	20.8	17.9	19.5	21.7	24.4	25.3	28.2	30.1	29.0
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.4	0.4	0.2	0.4	0.8	0.8	0.8	0.8	0.8
Amortization of Intangibles	1.1	1.1	1.1	1.1	1.1	1.0	0.8	0.8	0.8	-	-	-	1.1	-	-	-	-
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	23.8	20.7	24.4	52.9	35.5	39.1	36.7	42.7	49.6	39.6	48.5	67.5	71.3	71.0	67.3	69.8

Operating Income
Operating Income	(7.7)	(4.6)	(6.8)	(36.5)	(22.3)	(23.9)	(22.1)	(27.8)	(36.6)	(19.6)	(13.8)	(50.1)	(58.9)	(54.6)	(50.7)	(50.9)	(47.3)	(65.7)	(49.9)	(42.9)	(30.0)	(24.3)	(23.0)	(25.4)	(21.5)	(30.4)	(22.5)	(25.3)	(32.6)	(32.2)	(28.2)	(25.4)	(34.2)	(16.4)	(32.6)	(23.2)	(17.6)	(19.2)	(16.2)	(15.1)

Tax & Net
Income Tax Expense	5.1	(0.6)	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	-	-	-	-	-	-	-	-	-	0.9	1.4	-	-	0.0	0.0	-	-	-	-
Net Income From Continuing Ops	137.2	(5.4)	8.8	(11.7)	(24.7)	(26.3)	(26.7)	(28.8)	(39.0)	(29.0)	(10.7)	(59.3)	(55.1)	(57.4)	(53.1)	(53.9)	(49.5)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	137.2	(5.4)	8.8	(11.7)	(24.7)	(26.3)	(26.7)	(28.8)	(39.0)	(29.0)	(10.7)	(59.3)	(55.1)	(57.4)	(53.1)	(53.9)	(49.5)
Net Income Attributable To Parent	110.4	(3.9)	5.9	15.5	(10.6)	(6.8)	(12.9)	(10.9)	(15.4)	(9.3)	(5.0)	(24.8)	(21.5)	(26.9)	(22.5)	(21.4)
Less: Minority Interest	26.8	(1.5)	3.0	(27.1)	(14.1)	(19.5)	(13.8)	(17.9)	(23.6)	(19.7)	(5.7)	(34.5)	(33.6)	(30.5)	(30.5)	(32.6)	(33.7)
Less: Preferred Dividends	2.0	-	2.2	-	2.1	-	2.2	-	2.4	2.0	2.0	2.0	2.0	2.0	2.0	2.0	2.0
Net Income To Common Shareholders	108.4	(6.2)	3.7	13.4	(12.7)	(9.7)	(15.0)	(13.3)	(17.9)	(11.2)	(7.1)	(26.9)	(23.5)	(29.0)	(24.5)

Per Share
EPS Basic	3.44	-	0.13	0.50	(0.48)	-	(0.76)	(0.73)	(1.04)	-	(0.94)	(3.65)	(3.47)	-	(4.11)	(0.26)	(0.21)	-	(0.26)	(0.04)	(0.11)	-	-	-	(0.19)	-	-	-	0.03	-	-	-	(0.49)	-	-	-	-	-	-	-
EPS Diluted	2.82	-	0.11	0.45	(0.48)	-	(0.76)	(0.73)	(1.04)	-	(0.94)	(3.65)	(0.21)	-	(4.11)	(0.26)	(0.18)	-
Shares Basic	31.5	-	27.2	26.9	26.5	-	19.7	18.3	17.2	-	7.5	7.4	6.8	-	6.0	88.7	86.3	-
Shares Diluted	38.4	-	33.1	29.8	26.5	-	19.7	18.3	17.2	-	7.5	7.4	101.9	-	6.0	88.7	86.3	-

Supplementary Data
EBITDA	(7.6)	(4.5)	(6.7)	(36.4)	(22.2)	(23.8)	(22.0)	(27.4)	(36.2)	(19.4)	(13.4)	(49.3)	(58.0)	(53.9)	(49.9)	(50.1)	(46.5)	(65.0)	(49.2)	(42.3)	(29.4)	(23.8)	(22.4)	(24.8)	(21.0)	(29.9)	(22.0)	(24.8)	(32.1)	(31.7)	(27.8)	(25.1)	(34.0)	(16.3)	(32.4)	(23.0)	(16.9)	(18.6)	(16.0)	(15.1)
EBIT	(7.7)	(4.6)	(6.8)	(36.5)	(22.3)	(23.9)	(22.1)	(27.8)	(36.6)	(19.6)	(13.8)	(50.1)	(58.9)	(54.6)	(50.7)	(50.9)	(47.3)	(65.7)	(49.9)

Non-Operating
Interest Income	0.6	0.6	0.7	0.6	0.5	0.5	0.6	0.7	0.8	0.7	0.5	0.7	1.0	0.7	0.4	0.2	0.1	0.1	0.1	0.1	0.2	0.3	0.3	0.3	0.6	0.6	0.7	0.8	0.4	0.3	0.3	0.3	0.3	0.3	0.2	0.2	0.1	0.1	0.1	0.1
Interest Expense	3.4	2.0	2.7	2.5	2.8	2.6	6.2	2.1	2.6	2.1	2.5	6.4	4.3	3.6	3.4	3.2	2.4	5.9
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	150.0	(1.4)	15.7	24.8	(2.4)	(2.1)	(4.5)	(1.0)	(2.5)	(9.0)	3.2	(9.2)	3.7	(2.4)	(2.3)	(3.0)	(2.2)
Pre-Tax Income	142.3	-	8.9	-	(24.7)	-	(26.6)	-	-	-	(10.6)	-	-	-	(53.1)	-	-